SCHEMBL30579477

SCHEMBL30579477

Cc1[nH]c2c(F)cc(F)cc2c1CCNc1nc(-c2cncc(F)c2)nc2c1ncn2C(C)C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 13/20 0.40
▸ CDK5R1 Q15078 13/20 0.40
▸ CDK1 P06493 10/20 0.40
▸ CCNB2 O95067 9/20 0.40
▸ CCNB1 P14635 9/20 0.40
▸ CCNB3 Q8WWL7 9/20 0.40
▸ AHR P35869 1/20 0.38
▸ CCNK O75909 1/20 0.35
▸ CDK12 Q9NYV4 1/20 0.35
▸ CDK2 P24941 5/20 0.34
▸ CCNE1 P24864 4/20 0.34
▸ CCNE2 O96020 3/20 0.34
▸ CCNA2 P20248 3/20 0.34
▸ CCNA1 P78396 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CDK9 P50750 2/20 0.34
▸ CCNT1 O60563 1/20 0.33
▸ CDK7 P50613 1/20 0.33
▸ CCNH P51946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20542014 1.00 CDK5 (0.40) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL20541983 0.92 NTRK1 (0.41) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL20557731 0.88 CDK5 (0.41) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL30579354 0.87 AHR (0.43) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL2356743 0.87 AHR (0.43) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL20542274 0.86 CDK5 (0.40) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL21240842 0.80 CDK2 (0.42) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL2316607 0.78 CDK2 (0.44) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL30315335 0.78 CDK2 (0.44) CDK5CDK5R1CDK1CCNB2CCNB1
SCHEMBL2358503 0.78 CDK2 (0.43) CDK5CDK5R1CDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110831600-B Indole AHR inhibitors and uses thereof 医肯纳肿瘤学公司 2023-10-17 — — CN disclosed
Send feedback